Lv5
1358 积分 2022-10-21 加入
Oral GLP-1 Receptor Agonists for Weight Loss
17小时前
已完结
Animal models for development of anti-obesity drugs in the Age of GLP-1 Agents
18小时前
已完结
Clinical Guidelines on Nonalcoholic Fatty Liver Disease
2天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
23天前
已完结
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
30天前
已完结
Prediction model for postoperative severe acute lung injury in patients undergoing acute type A aortic dissection surgery
1个月前
已完结
体外循环肺损伤的保护性策略
1个月前
已关闭
TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial
1个月前
已关闭
皖公网安备34019202002308
